English | Español

Abbvie
Jamie Barrand | Jan 13, 2016

Enrollment underway for RA therapy clinical trials
Jamie Barrand | Jan 13, 2016

FDA grants priority review to new leukemia therapy
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

Jamie Barrand | Jan 6, 2016

Study of follicular lymphoma combination therapy shows promise
Jamie Barrand | Dec 29, 2015

AbbVie researchers publish results of Venetoclax study
Jamie Barrand | Dec 3, 2015

FDA approves new drug application for hepatitis C therapy
Jamie Barrand | Dec 1, 2015

AbbVie launches hyperthyroidism education program
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results

Trending
Patient Daily | Aug 12, 2025

Capitol Breathe Free Otolaryngologist on air quality and pollution: ‘These are common triggers for sinus inflammation and sinus infections’
+ Regulatory
Patient Daily | Aug 14, 2025

Founder of Policy Candy: '340B must see comprehensive reforms'
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 14, 2025

PhRMA COO on 340B: 'Hidden tax on patients, taxpayers & employers'